Eosinophilia in routine blood samples and the subsequent risk of hematological malignancies and death

Christen Lykkegaard Andersen, Volkert Dirk Siersma, Hanne Lindegaard, Hanne Vestergaard, Peter Felding, Niels de Fine Olivarius, Ole Weis Bjerrum

39 Citationer (Scopus)

Abstract

Eosinophilia may represent an early paraclinical sign of hematological malignant disease, but no reports exist on its predictive value for hematological malignancies. From the Copenhagen Primary Care Differential Count (CopDiff) Database, we identified 356,196 individuals with at least one differential cell count (DIFF) encompassing the eosinophil count during 2000-2007. From these, one DIFF was randomly chosen and categorized according to no (
OriginalsprogEngelsk
TidsskriftAmerican Journal of Hematology
Vol/bind88
Udgave nummer10
Sider (fra-til)843-7
Antal sider5
ISSN0361-8609
DOI
StatusUdgivet - okt. 2013

Fingeraftryk

Dyk ned i forskningsemnerne om 'Eosinophilia in routine blood samples and the subsequent risk of hematological malignancies and death'. Sammen danner de et unikt fingeraftryk.

Citationsformater